Using two independent immunohistochemical scoring systems, we found that estrogen receptor expression was not significantly different between primary and paired relapsed HGSOC patients; this finding was independent of the tumor’s sensitivity to platinum-based chemotherapy. This evidence concerns the gene ESR1 and neoplasm.